YYYiyan Yu

Yiyan Yu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yiyan Yu has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Whole-Virus Screening Coupled with Uncertainty-Aware Deep Learning Enables Discovery of Virus-Binding scFvs

    by Kailin Feng, Jonathan Parkinson, Ryan Hard, Dan Wang, Zekai Zhao, Yiyan Yu, Zhidong Zhou, Rui Wang, Jiayuan Alex Zhang, Edward Zhang, et al.

    Discovery of virus-binding ligands against emerging viral pathogens is of broad interest for diagnostics and therapeutic development. Here, we present an integrated framework that combines whole-virus screening using yeast surface display with uncertainty-aware deep learning and in silico directed evolution for the discovery and optimization of virus-binding single-chain variable fragments (scFvs). Using dengue virus (DENV) as a model system, millions of scFv sequences obtained from iterative whole-virus selections were analyzed by an uncertainty-aware deep learning model to predict virus binding while quantifying prediction uncertainty. Guided by these predictions, an in silico directed evolution algorithm introduced targeted mutations within complementarity-determining regions (CDRs) to improve predicted binding together with developability-related properties, including solubility and humanness. Experimental validation demonstrated measurable DENV binding by two independently AI-designed scFvs, providing proof of concept for the proposed framework.

  • Cellular Nanoparticle–Probiotic Biohybrid for Multimodal Oral Therapy of Food Allergy

    by Lei Sun, Wei-Ting Shen, Jiayuan Alex Zhang, Yiyan Yu, Dean Bai, Kailin Feng, Zhongyuan Guo, Zhidong Zhou, Weiwei Gao, Liangfang Zhang

    Food allergies, driven by abnormal immune responses to dietary allergens, can cause severe and potentially life-threatening reactions. Current treatments remain limited by partial efficacy and prolonged regimens. Here, we present a biohybrid formulation composed of macrophage membrane-derived nanoparticles and Escherichia coli Nissle 1917 probiotics for targeted, multimodal oral therapy of food allergies. The nanoparticles are loaded with an allergen-degrading enzyme and conjugated onto probiotics via click chemistry. This design enables the biohybrid to neutralize pro-inflammatory cytokines, degrade allergens, and enhance intestinal targeting and retention. In vitro, the formulation demonstrated strong cytokine binding and effective allergen degradation. In mouse models of casein- and gluten-induced allergies, oral treatment with the biohybrid suppresses inflammatory cytokines, restores gut microbiota diversity, and alleviates symptoms such as weight loss, diarrhea, and elevated immunoglobulin E levels. Histological analysis shows preserved intestinal structure, and no systemic or gastrointestinal toxicity is observed, indicating good tolerability of the biohybrid system.

  • Bacterial Membrane Coating Potentiates Lipid Nanoparticles for mRNA Delivery

    by Rui Wang, Lin Bao, Yiyan Yu, Runhe Zhang, Zhongyuan Guo, Luke J. Kubiatowicz, Nishta Krishnan, Ilkoo Noh, Edward Wang, Ronnie H. Fang, et al.

    Bacterial outer membrane vesicles (OMVs) possess intrinsic immunostimulatory properties by carrying native antigens and pathogen-associated molecular patterns (PAMPs). Lipid nanoparticles (LNPs) have become the leading platform for messenger ribonucleic acid (mRNA) delivery, underpinning the clinical success of mRNA vaccines. Here, we developed a hybrid nanoparticle formulation, OMV-coated LNPs (OMV-LNPs), that combines the high delivery efficiency of LNPs with the immunogenicity of the OMVs to enhance gene delivery. Using Escherichia coli-derived OMVs and dengue virus (DENV) E80 protein as a model antigen, we generated OMV-LNPs encapsulating DENV mRNA (OMV-LNPmRNA). These nanoparticles demonstrated improved uptake by lymph-node-resident immune cells and enhanced cytosolic mRNA delivery, resulting in robust dendritic cell maturation and proinflammatory cytokine production in vitro. In AG129 mice, the OMV-LNPmRNA elicited significantly higher titers of DENV-neutralizing antibodies compared to conventional LNPs. Collectively, these results establish OMV-LNPs as a versatile and potent platform for effective mRNA vaccine delivery.


  • Natural Macrophage Membrane-Coated Nanoparticles as a Multifaceted Sepsis Therapeutic to Sequester Inflammatory and Toxic Mediators

    by Alexandria Hoffman, Elisabet Bjånes, Zhidong Zhou, Amirah Onanuga, Anh T.P. Ngo, Shawn Hannah, Natalie Chavarria, Samira Dahesh, Brooke T. Tran, Angela Meier, et al.

    Bacterial sepsis is a life-threatening immune dysregulation triggered by bacterial infection and propagated by a dysfunctional host response, culminating in systemic tissue damage and multiorgan failure. In the United States, sepsis results in the hospitalization of more than one million patients annually and accounts for nearly one in three hospital deaths. Despite decades of efforts to develop immunoregulatory sepsis therapies, no clinically approved treatments exist. Recent advances in nanotechnology have introduced innovative approaches, including cellular nanodecoys synthesized from natural macrophage membranes coated onto polymeric nanoparticle cores. Here we introduce a human macrophage membrane-derived drug candidate, CTI-111, capable of sequestering soluble microbial toxins, drivers of inflammation, and pro-inflammatory cytokines from multiple sources. Therapeutic administration of CTI-111 reduces inflammation and improves survival in multiple murine sepsis models. We further demonstrate that CTI-111 can bind multiple sepsis-associated human cytokines in the complex environment of septic serum ex vivo. Together, these findings highlight the potential of CTI-111 as a multifaceted therapy for sepsis.


  • Dual-Action Cellular Nanoparticles for Effective Lead (Pb 2+ ) Detoxification

    by Wei-Ting Shen, Jiayuan Alex Zhang, Yiyan Yu, Sydney D. Zhang, Lei Sun, Mingxuan Kai, Weiwei Gao, Liangfang Zhang

    Lead (Pb2+) exposure remains a persistent and serious public health concern due to its widespread presence and profound toxicity. Building on recent advances in toxin-neutralizing cell membrane-coated nanoparticles (CNPs) and the discovery of Pb2+-binding DNA aptamers, we develop dual-action neuron-mimetic CNPs for effective Pb2+ detoxification. In the formulation, the CNPs encapsulate aptamers within metal-organic framework (MOF) cores and coated with membranes derived from SH-SY5Y neuroblastoma cells, two functional components working together to neutralize Pb2+. The resulting constructs, termed Neuron-MOF/aptamer-NPs, exhibit strong Pb2+ binding capacity, excellent colloidal stability in physiological media, and resistance to DNA leakage. In vitro assays identify Neuron-MOF/aptamer-NPs as the most potent formulation, demonstrating dual-action neutralization against Pb2+-induced toxicity, oxidative stress, and lipid peroxidation in SH-SY5Y cells. In vivo, Neuron-MOF/aptamer-NP treatment significantly improves survival in a mouse model of lead poisoning and reduces hematologic, hepatic, and renal damage. Behavioral assessments further confirm the restoration of spatial memory and locomotor function. Neuron-MOF/aptamer-NPs exhibit no signs of acute toxicity in healthy mice. These findings establish Neuron-MOF/aptamer-NPs as a potent and biocompatible therapeutic platform for targeted lead detoxification with systemic and neuroprotective benefits.


  • Neuronal Membrane-Functionalized Biohybrid Microrobots for Active Decontamination of Neurotoxins in Aqueous Environments

    by Zhengxing Li, Hao Luan, Zheng Fang, Wei-Ting Shen, Yiyan Yu, Junyi Ji, Robert Kobrin, Jiayuan Alex Zhang, Sven Neuschul, Wesley Tse, et al.

    The emergence of biohybrid microrobots offers a promising platform for environmental remediation; however, their potential for neurotoxin decontamination remains largely unexplored. Neurotoxins, such as tetrodotoxin (TTX), pose acute threats to aquatic biodiversity with far-reaching consequences for public health. The removal of TTX from aquatic environments presents a critical challenge, necessitating innovative and adaptive strategies. Here, we present a neuronal membrane-functionalized algae-based microrobot platform for the autonomous and selective detoxification of TTX in various aquatic environments. By integrating the natural long-lasting motility of green algae Micromonas pusilla with neuronal membranes with intrinsic TTX-binding receptors, this self-propelled biohybrid microrobot acts as a motile neuron decoy that enables dynamic "on-the-fly" interactions with TTX, significantly enhancing neutralization efficiency in natural river and seawater environments. Moreover, the active penetration abilities of the biohybrid microrobots allow for effective toxin removal from confined complex three-dimensional (3D) microporous networks, such as riverbeds and seabeds, where diffusion-based methods are often ineffective. The microrobot platform further demonstrates exceptional adaptability, maintaining robust detoxification performance across diverse environmental conditions including fluctuations in pH, temperature, and dissolved oxygen levels. By leveraging biohybrid intelligence and environmental adaptability, this work establishes an innovative strategy for sustainable, efficient, and versatile neurotoxin remediation in dynamic aquatic environments.


  • Controlled Dimerization of Cellular Nanodiscs via Click Chemistry to Enhance Immune Compatibility

    by Lei Sun, Yiyan Yu, Jiayuan Alex Zhang, Wei-Ting Shen, Kailin Feng, Dean Bai, Zhidong Zhou, Weiwei Gao, Liangfang Zhang

    Cellular nanodiscs (CNDs), assembled from cell membrane fragments and stabilized with scaffold molecules, have emerged as a promising biomimetic platform for drug delivery, countermeasures, and vaccination. However, the exposure of inner membrane components in the current CND constructs, such as phosphatidylserine (PS) can trigger immune recognition and rapid clearance, thereby limiting their therapeutic efficacy. To address this issue, here we report on a unique approach to dimerizing CNDs in a precisely controlled, back-to-back manner by covalently linking two monomeric CNDs via click chemistry, aiming to shield the immunogenic inner membrane components. Compared with monomeric CNDs, the resulting dimeric CNDs showed reduced PS exposure, decreased macrophage uptake, and prolonged circulation in vivo. In mouse models of acute lung injury and systemic inflammation, dimeric CNDs achieved superior cytokine suppression and favorable biodistribution with minimal short-term toxicity. These findings demonstrate that CND dimerization can effectively enhance immune compatibility and greatly improve in vivo performance, advancing the application potential of cell membrane-derived CND technology.


  • Open Access

    Picoeukaryote-based biohybrid microrobots for active delivery in the kidney

    by Zhengxing Li, Dan Wang, Hao Luan, An-Yi Chang, Zheng Fang, Lei Sun, Junyi Ji, Wei-Ting Shen, Yiyan Yu, Yiyang Yan, et al.

    Confined spaces in the human body pose substantial challenges for biomedical procedures. Navigating these ultrasmall environments is essential for precise drug delivery, improving treatment outcomes and reducing adverse effects. Microrobots offer a promising approach to accessing these complex microenvironments. Here, we show a biohybrid microrobot based on picoeukaryotes, engineered as a cargo carrier for active delivery in tight in vivo spaces. The microrobot exhibits strong in vitro motility through narrow two-dimensional and complex three-dimensional networks and, in vivo, achieves outstanding kidney penetration, uniform distribution, and >48-hour retention while resisting flow shear and immune clearance, with excellent biosafety. Their ability to retain functionality and sustain propulsion within the confined and complex kidney vasculatures and interstitial spaces underscore their potential for long-term, active delivery in confined biological environments. The picoeukaryote-based biohybrid microrobot system represents a major advancement in active drug delivery, especially tailored to the challenging microenvironments of the kidney.


  • Open Access

    Hepatic endoplasmic reticulum-derived nanodiscs for broad-spectrum drug detoxification

    by Lei Sun, Kailin Feng, Dean Bai, Yiyan Yu, Wei-Ting Shen, Jiayuan Alex Zhang, Ronnie H. Fang, Weiwei Gao, Liangfang Zhang


  • Open Access

    Recent Development of Nanoparticle Platforms for Organophosphate Nerve Agent Detoxification

    by Kailin Feng, Jiayuan Alex Zhang, Wei-Ting Shen, Tianle Leng, Zhidong Zhou, Yiyan Yu, Weiwei Gao, Liangfang Zhang

    Poisoning by organophosphate (OP) nerve agents remains a pressing global threat due to their extensive use in chemical warfare agents and pesticides, potentially causing high morbidity and mortality worldwide. This urgent need for effective countermeasures has driven considerable interest in innovative detoxification approaches. Among these, nanoparticle technology stands out for its multifunctional potential and wide-ranging applications. This review highlights recent advancements in nanoparticle platforms developed for OP detoxification, focusing on five main types: inorganic nanoparticles, lipid-based nanoparticles, polymer-based nanoparticles, metal-organic framework nanoparticles, and cellular nanoparticles. For each platform, we discuss representative examples that illustrate how structural and functional properties enhance their effectiveness as nanocarriers, nanocatalysts, or nanoscavengers, ultimately enabling safe and efficient OP detoxification. This review aims to stimulate further technological innovation in OP-detoxifying nanoparticles and encourage broader development of detoxification strategies.